Carregant...
GLP-1/glucagon receptor co-agonism for treatment of obesity
Over a relatively short period, obesity and type 2 diabetes have come to represent a large medical and economic burden to global societies. The epidemic rise in the prevalence of obesity has metabolic consequences and is paralleled by an increased occurrence of other diseases, such as diabetes, canc...
Guardat en:
| Publicat a: | Diabetologia |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer Berlin Heidelberg
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6448809/ https://ncbi.nlm.nih.gov/pubmed/28733905 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00125-017-4354-8 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|